Co-treatment with hepatocyte growth factor and TGF-beta1 enhances migration of HaCaT cells through NADPH oxidase-dependent ROS generation. [electronic resource]
- Experimental & molecular medicine Apr 2010
- 270-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't